Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OptiMized REsistaNt Starch in Inflammatory Bowel Disease: The MEND Trial

NCT04520594 is registered in ClinicalTrials.gov with Children's Hospital of Eastern Ontario as lead sponsor.

NCT NCT04520594
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04520594 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OptiMized REsistaNt Starch in Inflammatory Bowel Disease: The MEND Trial
Lead sponsor
Children's Hospital of Eastern Ontario
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 3, 2021
Completion date
December 31, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease, inflammatory bowel diseases, ulcerative colitis